Indivior Pharmaceuticals, Inc. INDV Business Segments — Gross Profit

Similar metrics at other companies

DLTRReportable Segment — Gross Profit

$1.83B+10.9%

GWREReportable Segment — Gross Profit

$236.65M+29.5%

CHWYReportable Segment — Gross Profit

$1.01B+9.5%

FPSReportable Segment — Gross Profit

$131.2M+92.5%

YETIReportable Segment — Gross Profit

$210.21M+4.2%

MNTSReportable Segment — Gross Profit

$1.82M+464%

FAQ

What is Indivior Pharmaceuticals, Inc.'s business segments — gross profit?

Indivior Pharmaceuticals, Inc. (INDV) reported business segments — gross profit of $277M in Q1 2026.

How has Indivior Pharmaceuticals, Inc.'s business segments — gross profit changed year-over-year?

Indivior Pharmaceuticals, Inc.'s business segments — gross profit increased by 25.3% year-over-year, from $221M to $277M.

What is the long-term trend for Indivior Pharmaceuticals, Inc.'s business segments — gross profit?

Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc.'s business segments — gross profit has grown at a 9.9% compound annual growth rate (CAGR), from $749M to $993M.

What does business segments — gross profit mean?

Calculated as net revenue minus the cost of sales for the reportable segment. It reflects the core profitability of the segment's product portfolio before accounting for operating expenses.